(Q41272702)
Statements
Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study (English)
Ranjana Advani
Maria Corinna A Palanca-Wessels
Myron Czuczman
Gilles Salles
Sarit Assouline
Laurie H Sehn
Manish R Patel
Randeep Sangha
Anton Hagenbeek
Herve Tilly
Sreeni Yalamanchili
Robert Kahn
Randall C Dere
Dan Lu
Surai Jones
Cheryl Jones
Yu-Waye Chu
Franck Morschhauser